Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RCVS Christmas donation given to Medical Detection Dogs
"We are very grateful for this generous donation from the RCVS which will help us continue our mission to train dogs to save lives" - Claire Guest, MDD CEO.

The charity trains dogs to detect odours of human diseases.

The RCVS has announced the recipient of this years' Christmas donation as Medical Detection Dogs (MDD).

Chosen by RCVS president Dr Kate Richards, Medical Detection Dogs trains canines to detect the odours of human diseases at early stages. 

Previous recipients of the annual donation include StreetVet, The American Fondouk, Iris's Cats in Need and The Country Trust. 

Kate discussed her choice: “Medical Detection Dogs is One Health in action, demonstrating the connection and inter-dependency between people and animals. 

“The charity trains dogs to detect the odour of human diseases and is now trialling dogs in real-life settings to detect the odour of Covid-19. Their results indicate that dogs perform better than the lateral flow test. 

“The study, still to be peer reviewed, indicates that using dogs will be considerably faster than existing testing methods since one dog can screen up to 250 people in an hour. Despite the advances in technology, these dogs are at the sniffing edge of science.”

Claire Guest, MDD CEO, commented on the donation: “We are very grateful for this generous donation from the RCVS which will help us continue our mission to train dogs to save lives using their amazing sense of smell.

“We share a joint appreciation and understanding of just how incredible our wet-nosed companions are and the work of MDD shows that the future of disease diagnosis could be held in their paws.

“Our dogs have already successfully proven that they are superior to any technology when detecting the odour of diseases like cancer, Parkinson’s and malaria and conditions like Type 1 diabetes and postural tachycardia syndrome.

“Now, at a time when the pandemic is affecting us all either directly or indirectly, they are also on the cusp of being an extra, fast, accurate layer of defence to help keep us safe and keep the world moving.”

Image (C) Neil Pollock, Medical Detection Dogs

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.